Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

BACKGROUND AND AIMS: Dual immune checkpoint blockade (ICB) therapy can result in immune-related-adverse events (irAE) such as ICB-hepatitis. An expansion of effector-memory (TEM) CD4 T cells associated with antiviral immunity against herpesviridae was implicated in ICB-hepatitis. Notably, these memo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhen, Rafei-Shamsabadi, David, Lehr, Saskia, Buettner, Nico, Diehl, Rebecca, Huzly, Daniela, Pinato, David J, Thimme, Robert, Meiss, Frank, Bengsch, Bertram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743538/
https://www.ncbi.nlm.nih.gov/pubmed/36503532
http://dx.doi.org/10.1186/s12967-022-03755-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743538/
https://www.ncbi.nlm.nih.gov/pubmed/36503532
http://dx.doi.org/10.1186/s12967-022-03755-3

Ejemplares similares